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Effects of Smoking Cessation on Body Composition
in Postmenopausal Women
Alison Kleppinger, M.S.,1 Mark D. Litt, Ph.D.,2 Anne M. Kenny, M.D.,1 and Cheryl A. Oncken, M.D.3
Abstract
Background: Smoking cessation is associated with weight gain, but the effects of smoking cessation on measures
of body composition (BC) have not been adequately evaluated. The purpose of this study is to examine the
effects of 16 months of cigarette abstinence on areas of BC measured by dual-energy x-ray absorptiometry
(DXA).
Methods: One hundred fifty-two postmenopausal women participated in a smoking cessation study using the
nicotine patch. Secondary analyses were conducted on data from 119 subjects (age 56 7 years, range 41–78
years) who had had DXA scans at baseline and 16 months later. Participants were classified either as quitters
(self-reported cigarette abstinence confirmed with exhaled carbon monoxide [co] 8 ppm at 3 and 16 months
after quit date) or as continued smokers. BC was assessed using a General Electric Lunar DXA IQ machine. Four
areas of BC (kg) were measured: whole body weight, fat mass, muscle mass, and functional skeletal muscle mass
in arms and legs (ASM/ht2). Multivariate analysis of covariance (MANCOVA) assessed changes in BC in
quitters vs. continued smokers between baseline and 16 months of follow-up. Increases in BC measures were
evaluated as a function of increased calorie intake or change in physical activity, using linear regression.
Results: Quitters significantly increased body weight ( p< 0.001), fat mass ( p< 0.001), muscle mass ( p¼ 0.04),
and functional muscle mass ( p¼ 0.004) over time, when baseline BC measures and other confounding factors
were controlled. Regression analysis indicated change in BC could not be accounted for by calorie intake or
physical activity.
Conclusions: Smoking cessation may be associated with increased fat and muscle mass in postmenopausal
women. The novel finding of an increase in functional muscle mass suggests that smoking cessation could
increase functional capacity. Further studies need to replicate these findings and examine mechanisms of these
effects.
Introduction
Cigarette smoking cessation is associated with weightgain (i.e., 6–12 pounds/2.7–5.4 kg) in the first year of
abstinence.1–6 The effect of smoking cessation on weight gain
may be even greater in postmenopausal women,whenweight
gain naturally occurs.6 The mechanisms underlying weight
gain with smoking cessation are likely multifaceted and may
include increased calorie intake, decreased metabolism, and
changes in physical activity.4,7–10 Weight gain from smoking
cessation not only has become a barrier to quitting but also
increases the risk of relapse among female smokers.11–15
Although the association between smoking cessation and
weight gain is well established, it is not known if the effect is
through increases in body fat, muscle, or both. The relation-
ship between smoking and body fat is complex, with cross-
sectional studies showing that smokers have higher waist
circumference (a measure of central adiposity) than non-
smokers and also lower body mass index (BMI)16–21 and de-
creased overall body fat.22 In older populations, smoking is
also associated with an increased risk of sarcopenia (age-
related muscle loss).23–25 Consequently, it seems possible
that smoking cessation could increase lean and fat tissue. If
smoking cessation increases muscle mass, this may be an
added inducement to persuade people to quit smoking.
The purpose of this report was to examine the effects of
smoking cessation on body composition (BC) in postmeno-
pausal women. We conducted a secondary analysis of a
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randomized, longitudinal trial evaluating nicotine vs. placebo
patch treatment (3 month treatment and 1 month taper)
on long-term smoking cessation rates in postmenopausal
women.6,26 Dual-energy x-ray absorptiometry (DXA) scans
were obtained before smoking cessation and again 16 months
later.6 In addition to measuring bone mineral density (BMD),
DXA technology provides a valid measurement of BC (lean
and fat tissue) as well as functional muscle mass (appendicular
skeletal mass/ height2 [ASM/ht2]).27,28 We are not aware of
any studies to date that have evaluated the effects of smoking
cessation on changes in these BC measures.
Materials and Methods
Subjects
One hundred fifty-two postmenopausal women partici-
pated in a smoking cessation study examining the adjunctive
use of the nicotine vs. placebo patch combined with group
behavioral counseling for smoking cessation.6 This study was
approved by the institutional review board at the University
of Connecticut, and all subjects signed a written informed
consent form.
Womenwere eligible if they smoked at least 10 cigarettes per
day andwere postmenopausal (i.e., nomenstruation for at least
1 year). Exclusion criteria included (1) taking oral corticoste-
roids, antiepileptics, ormedication for prevention/treatment of
osteoporosis other than hormone replacement therapy (HRT),
(2) untreated parathyroid or thyroid disease, multiple mye-
loma, or insulin-dependent diabetes mellitus, (3) a recent frac-
ture, (4) an ionized calcium concentration >1.36mmol/L, (5)
consuming more than two alcoholic drinks per day, (6) using
nicotine replacement or tobacco products other than cigarettes,
(7) an unstable psychiatric status (i.e., current major depres-
sive disorder [MDD] as determined by a Structured Clinical
Interview for DSM-IV (SCID) interview29 or psychosis);
women who were currently taking antidepressants and who
did not meet criteria for current MDDwere not excluded from
study participation, and (8) an unstable medical condition.
Women were randomly assigned with a 3:5 randomization
scheme to nicotine patch (21mg for 3 months, 14mg for
2 weeks, 7mg for 2 weeks) or placebo patch and received
group behavioral counseling for smoking cessation. In addi-
tion, women were followed for approximately 12 months
after patch discontinuation for cigarette abstinence and other
measures. There was no overall advantage of the nicotine
vs. the placebo patch on quit rates (35% quit rate in both
groups) at the end of the follow-up period.6 We, therefore,
combined the participants from both conditions for the ana-
lyses presented here. Complete data, including DXA scans at
visit 2 (prior to treatment) and at visit 8 (16 months after quit
date) were obtained for 119 women. At 16 months, 42 (35.3%)
participants were considered abstinent from smoking (quit-
ters), and 77 (64.7%) remained smokers.
Measures and instruments
Outcome variables. Four measures of BC were exam-
ined in this study: total body weight (kg), lean muscle (kg),
fat tissue (kg), and functional muscle (ASM/ht2 in kg/m2).
Tissue masses were determined using DXA with a DXA IQ
scanner (GE Medical Systems Lunar, Madison, WI). All scans
were obtained by the same certified technician. DXA is a valid
and reliable means to collect total body fat and lean muscle.27
DXA measures BC by distinguishing between the soft tissue
mass and the bone mineral content. The coefficients of vari-
ation (CV) for BC measurements (based on reproducibility
scans) were 2.98% for fat and 1.85% for lean tissue. Fat tissue is
separated from the soft tissue using the DXA machine soft-
ware. Lean tissue is calculated from soft tissue by subtracting
out the fat tissue. ASMwas determined by combining the lean
tissue mass of the arms and legs, excluding all other body
regions from analysis.28 We adjusted ASM (kg) for height by
dividing each by height2 (m2). Height was measured using a
stadiometer, and total body weight was calculated by the
DXA software as total bodymass (kg). Previous studies define
ASM/ht2 as functional muscle, as it includes the arm and leg
skeletal muscles, which aid in our ability to move.28
Smoking cessation status. Subjects were categorized as
quitters if they reported 7-day point prevalence abstinence
confirmed with an exhaled carbon monoxide (CO) value of
<8 ppm at visit 7 (3months) and again at visit 8 (16months).30
Subjects who did not report abstinence at visits 7 and 8 were
considered smokers.
Potential mediators. Conceptually, mediators are factors
through which interventions influence outcomes. Mediators
lie on the causal path between the independent and depen-
dent variables.31 It was hypothesized that smoking cessation
could affect BC by altering food intake and exercise; both of
which affect either calorie intake or calorie metabolism. Food
intakewas assessed using a 4-day food diary. Physical activity
level was measured using the Physical Activity Scale for
the Elderly (PASE). These were measured at baseline and at
3 months.
Food diary. One documented effect of smoking is to
suppress appetite.8 Increase in appetite has been suggested as
one reason that smoking cessation causes weight gain. To
evaluate calorie intake, a 4-day example of each participants’
daily eating habits was entered on dietary records. The die-
tary records were analyzed by using Food Processor II
Nutrient Analysis Program software (ESHA Research, Inc.,
Salem, OR). Calorie intake was obtained from this food diary
analysis.
PASE. BC may change with increased physical activity
and, thus, mitigate other effects of quitting on weight gain.
The PASE is a relatively brief, reliable, and valid instrument
for the assessment of physical activity in older people. It
has high test-retest reliability of 0.75 and has been correlated
with measures of physical fitness, such as grip strength, leg
strength, and balance.32
Statistical analyses
All continuous variables were checked for normality.
Correlations were run to investigate any associations among
predictors and outcomes. Baseline characteristics between
treatment groups were compared using analysis of variance
(ANOVA) or chi-square tests. Multivariate analyses of co-
variance (MANCOVA)with univariate posttests were used to
determine if smoking cessation was associated with BC after
16 months. The four outcome variables assessed in the
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MANCOVA were total body weight (kg), lean mass (kg), fat
mass (kg), and ASM/ht2 (kg/m2) at 16 months. Univariate
posttests were performed to evaluate the effects of smoking
cessation between smokers and quitters on each outcome in-
dependently. Covariates for the MANCOVA were the base-
line values of all four BC measures.
A MANCOVA was also used to test the effects of smoking
cessation on two potential mediators of weight gain (calorie
intake and physical activity measured by PASE activity
score), adjusting for baseline BC measures. Both mediator
variables were measured at 3 months. Mediation analyses
were conducted using four hierarchical linear regression an-
alyses, one for each BC-dependent variable. For each analysis,
the BC measures were evaluated as a function of smoking
cessation (smokers vs. abstainers). In block 1, the following
covariates were entered: baseline BC measure, age, nicotine
treatment, number of cigarettes smoked per day at baseline,
HRT use, antidepressant use, and years since menopause. In
block 2, the mediator variables (calorie intake and PASE
score) were entered as residualized change scores (i.e., calorie
count or PASE score at 3 months after quit date with the
baseline calories or PASE score value covaried out). All sta-
tistics were performed using SPSS version 16.0 software
(SPSS, Chicago, IL).
Results
Baseline demographics and BC were not significantly dif-
ferent between the smokers and quitters (Table 1), with the
exception of years postmenopause, number of cigarettes
smoked per day, and antidepressant use. Smokers were 11
years postmenopausal, whereas quitters averaged 14 years
( p< 0.05). Quitters smoked an average of 18 cigarettes a day
at study entry, and continued smokers averaged 23 cigarettes
per day ( p< 0.05). Smokers were takingmore antidepressants
than quitters ( p< 0.01). Physical activity (PASE score) was
comparable between continued smokers and quitters (171
vs. 151, p¼ 0.18). The use of HRT was no different between
smokers and nonsmokers; however, quitters were less likely
to have a history of MDD, as previously reported.29
Overall, our analysis of BC showed a significant effect from
smoking cessation, such that those who quit smoking gained
significantly more weight. Women who had quit smoking
significantly increased in body weight, fat mass, lean mass,
and ASM/ht2 (multivariate tests, Wilks’ l¼ 0.76, p< 0.001).
Quitters gained 14 pounds (6.5 kg); most of the weight was fat
(13 pounds/5.8 kg), 1.5 pounds (0.7 kg) was muscle, and<0.5
pound (0.1 kg/m2) was functional muscle. Figure 1 displays
unadjusted absolute changes in each type of BC measure.
The MANCOVA results revealed smoking cessation as a
significant predictor of all BC measures. Univariate posttests
comparing quitters and smokers confirmed that body weight,
fat, lean muscle, and functional muscle significantly increased
in quitters (Fig. 1). MANCOVA results for the mediators
showed that smoking cessation was not significantly associ-
ated with changes in physical activity levels or calorie in-
take. Univariate posttests confirmed no differences between
quitters and continued smokers. Although the difference
was not significant, the average calorie intake in quitters at
3 months was marginally higher (1712 602) than in contin-
ued smokers (1547 538) ( p¼ 0.12). The average PASE score
was lower in quitters (169 75) than in smokers (175 91)
( p¼ 0.15). Quitters reported eating more calories daily and
engaging in less physical activity than smokers, but these
differences were not statistically significant.
Each of the linear regression models confirmed that
smoking cessation, adjusting for all of the covariates, main-
tained a significant effect on each of the four different types
of BC (Table 2). The percent of explained variance for these
models was very high (89%). Smoking cessation remained a
significant predictor of BC even when mediators (calorie in-
take and PASE change scores) were added in block 2 of each of
Table 1. Baseline Characteristics
Variable Quitters (n¼ 42) Smokers (n¼ 77) p valuea
Age 57.2 7.4 55.0 6.8 0.08
Body mass index 27.0 5.6 26.9 5.0 0.98
Weight, kg 68.9 15.5 70.0 14.4 0.70
Whole body fat mass, kg 27.1 11.2 27.4 10.4 0.84
Whole body lean mass, kg 39.4 5.3 40.0 5.1 0.51
ASM/ht2, kg/m2 6.22 0.77 6.21 0.81 0.93
Arm lean mass, kg 4.1 0.7 4.2 0.7 0.54
Leg lean, kg 12.1 1.9 12.3 1.9 0.67
Arm fat, % 34.8 9.4 35.5 9.5 0.67
Leg fat, % 42.1 8.7 40.9 7.2 0.43
Cigarettes smoked per day 17.8 4.9 22.9 8.8 0.001
Number of years smoked 33.5 11.3 34.8 9.6 0.46
Nicotine intervention patch, % 38 40 0.82
Years since menopause 14.5 10.1 10.6 8.1 0.03
Antidepressant medication, % 15 43 0.01
HRT use, % 49 49 0.94
Physical activity level or PASE score 171 86 151 77 0.18
Daily calorie intake 1719 584 1660 431 0.54
Caucasian, % 86 90 0.22
High school education or higher, % 72 72 0.75
ap values were based on independent t tests or chi-square tests.
ASM/ht2, appendicular skeletal mass/height2; HRT, hormone replacement therapy; PASE, physical activity scale for the elderly.
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the models. Given the failure of calorie intake change or PASE
score change to account for any of the variance attributable to
smoking cessation, the results indicate that smoking cessation
did not act to increase BC by increasing calorie intake or by
decreasing physical activity.
Discussion
The results of this study indicated that all measures of BC
were influenced by smoking cessation. Sustained abstinence
from smoking was associated with increases in total body
weight, fat mass, and lean and functional muscle mass. Most
of the weight gain in those who quit smoking was due to an
increase in fat mass, although there was also a statistically
significant increase in lean and functional muscle mass. We
consider this a novel and important finding on the benefits of
quitting smoking. Functional muscle changes were not large
in this project, but they may be clinically significant.
The results of this study are consistent with those of other
studies indicating that smoking cessation is associated with
an increased body weight. Further, it extends the literature by
showing that the majority of weight gain was due to an in-
crease in body fat. Given that caloric changes and physical
activity did not significantly change with quitting, it seems
probable that most of the changes in body weight resulted
from changes in metabolism, as noted in some previous
studies.7–10
An interesting findingwas that quittingwas also associated
with an increase in lean and functional muscle. This finding
is consistent with a few cross-sectional studies that show
that smoking is associated with an increased risk of sarcope-
nia.23–25 As far as we are aware, this is the first study to ex-
amine the effects of smoking cessation on muscle mass.
Although the mechanisms by which smoking causes sarco-
penia are unknown, two recent studies found that smoking
impairs protein muscle synthesis and increases expression
of genes associated with inhibition of muscle growth and
catabolism.33,34 There may be a metabolic effect by which
smoking impairs muscle synthesis, whereas there may be an
epigenetic mechanismwhere smoking increases expression of
genes associated with impaired muscle functioning. Future
studies could further elucidate mechanisms, examine poten-
tial gene by environment interactions, and evaluate whether
changes in functional muscle mass with smoking cessation
translate into improved functional capacity. Future directions
may also include determining if adding an exercise program
to smoking treatment increases cessation rates and has further
beneficial effects on BC measures (i.e., increases functional
muscle mass and decreases in fat mass) in postmenopausal
women.
It is noteworthy that, if replicated, the results of this study
may be useful clinically. Weight-concerned smokers have
poorer smoking treatment outcomes compared with smokers
with lower levels of weight concerns.8 Informing women that
some of the weight gain may be due to an increase in muscle
mass could help women better accept weight gain with
smoking cessation and thereby improve smoking treatment
outcomes.
The strengths of this study are a well-defined subject
population, biochemical measures of cigarette abstinence, and
good retention rates, given the length of follow-up. Limita-
tions of the study include some missing mediator values at
3 months (particularly in the smokers) that could influence
regression outcomes. There was no measure to account for
metabolism changes over the 16 months that may have
influenced BC. Measurements of muscle strength (e.g., hand
grip) that were used in other studies examining sarcope-
nia23,25 could have been useful in examining whether even
small changes in functional muscle were clinically significant.
Waist/hip ratio measurements could have been useful to
determine if distribution of body fat may have been altered
with smoking cessation.
FIG. 1. Unadjusted body composition changes in smokers vs. quitters after 16 months. p values based on univariate
posttests from the MANCOVA analysis. Bars represent the mean absolute change from baseline to 16 months in each body
composition measures. Error bars represent the variability within each smoking status grouping. MANCOVA, multivariate
analysis of covariance.
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In conclusion, smoking cessation is associated with an in-
crease in fat and muscle mass in postmenopausal women.
Further studies are needed to replicate these findings and to
examine mechanisms of these effects.
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